Eli Lilly EBIT 2010-2024 | LLY

Eli Lilly EBIT for the quarter ending September 30, 2024 was $4.353B, a 27.07% increase year-over-year.

  • Eli Lilly 2023 EBIT was 6.458B, a 9.39% decline from 2022.
  • Eli Lilly 2022 EBIT was 7.127B, a 12.12% increase from 2021.
  • Eli Lilly 2021 EBIT was 6.357B, a 4.94% increase from 2020.

EBIT can be defined as earnings before interest and taxes.

Eli Lilly EBIT 2010-2024 | LLY

  • Eli Lilly 2023 EBIT was 6.458B, a 9.39% decline from 2022.
  • Eli Lilly 2022 EBIT was 7.127B, a 12.12% increase from 2021.
  • Eli Lilly 2021 EBIT was 6.357B, a 4.94% increase from 2020.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$471.5B
Johnson & Johnson (JNJ)$373.6B
AbbVie (ABBV)$312.7B
Merck (MRK)$250.9B
Novartis AG (NVS)$213.1B
AstraZeneca (AZN)$203.5B
Pfizer (PFE)$145.4B
Sanofi (SNY)$122.5B
Innoviva (INVA)$1.2B